Expression Analysis of Same-Patient Metachronous and Synchronous Upper Tract and Bladder Urothelial Carcinoma. Letter.

Yuxuan Song,Yiqing Du,Caipeng Qin,Fan Bai,Tao Xu

DOI: https://doi.org/10.1097/ju.0000000000002698

IF: 7.6

2022-01-01

The Journal of Urology

Abstract:No AccessJournal of UrologyLetters to the Editor1 Jul 2022Expression Analysis of Same-Patient Metachronous and Synchronous Upper Tract and Bladder Urothelial Carcinoma. Letter. Yuxuan Song, Yiqing Du, Caipeng Qin, Fan Bai, and Tao Xu Yuxuan SongYuxuan Song Department of Urology, Peking University People's Hospital, Beijing, China More articles by this author , Yiqing DuYiqing Du Department of Urology, Peking University People's Hospital, Beijing, China More articles by this author , Caipeng QinCaipeng Qin Department of Urology, Peking University People's Hospital, Beijing, China More articles by this author , Fan BaiFan Bai Biomedical Pioneering Innovation Center (BIOPIC), Beijing Advanced Innovation Center for Genomics (ICG), School of Life Sciences, Peking University, Beijing, China Equal contributors. More articles by this author , and Tao XuTao Xu †Correspondence: Department of Urology, Peking University People's Hospital, Beijing100044, China telephone: +86 10 88325226; E-mail Address: [email protected] Department of Urology, Peking University People's Hospital, Beijing, China Equal contributors. More articles by this author View All Author Informationhttps://doi.org/10.1097/JU.0000000000002698AboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail "Expression Analysis of Same-Patient Metachronous and Synchronous Upper Tract and Bladder Urothelial Carcinoma. Letter.." The Journal of Urology, 208(1), pp. 222–223 References 1. : Expression analysis of same-patient metachronous and synchronous upper tract and bladder urothelial carcinoma. J Urol 2021; 206: 548. Link, Google Scholar 2. : High rate of pathologic upgrading at nephroureterectomy for upper tract urothelial carcinoma. Urology 2012; 79: 615. Google Scholar 3. : Discordance between ureteroscopic biopsy and final pathology for upper tract urothelial carcinoma. J Urol 2018; 199: 1440. Link, Google Scholar 4. : A consensus molecular classification of muscle-invasive bladder cancer. Eur Urol 2020; 77: 420. Google Scholar 5. : Upper tract urothelial carcinoma has a luminal-papillary T-cell depleted contexture and activated FGFR3 signaling. Nat Commun 2019; 10: 2977. Google Scholar 6. : Genomic profile of urothelial carcinoma of the upper tract from ureteroscopic biopsy: feasibility and validation using matched radical nephroureterectomy specimens. Eur Urol Focus 2019; 5: 365. Google Scholar 7. : An integrated multi-omics analysis identifies prognostic molecular subtypes of non-muscle-invasive bladder cancer. Nat Commun 2021; 12: 2301. Google Scholar 8. : Clonal relatedness and mutational differences between upper tract and bladder urothelial carcinoma. Clin Cancer Res 2019; 25: 967. Google Scholar 9. : Mutagenic factors and complex clonal relationship of multifocal urothelial cell carcinoma. Eur Urol 2017; 71: 841. Google Scholar 10. : The clonal relation of primary upper urinary tract urothelial carcinoma and paired urothelial carcinoma of the bladder. Int J Cancer 2021; 148: 981. Google Scholar © 2022 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 208Issue 1July 2022Page: 222-223 Advertisement Copyright & Permissions© 2022 by American Urological Association Education and Research, Inc.MetricsAuthor Information Yuxuan Song Department of Urology, Peking University People's Hospital, Beijing, China More articles by this author Yiqing Du Department of Urology, Peking University People's Hospital, Beijing, China More articles by this author Caipeng Qin Department of Urology, Peking University People's Hospital, Beijing, China More articles by this author Fan Bai Biomedical Pioneering Innovation Center (BIOPIC), Beijing Advanced Innovation Center for Genomics (ICG), School of Life Sciences, Peking University, Beijing, China Equal contributors. More articles by this author Tao Xu Department of Urology, Peking University People's Hospital, Beijing, China †Correspondence: Department of Urology, Peking University People's Hospital, Beijing100044, China telephone: +86 10 88325226; E-mail Address: [email protected] Equal contributors. More articles by this author Expand All Advertisement PDF DownloadLoading ...